BioCardia (STU:6JU0) E10: €-6.18 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:6JU0 BioCardia Inc STU:6JU0
17 GF Score
Price €0.27
GF Value €0.01
! 1 Warning Sign
View Full Analysis

What is BioCardia E10?

BioCardia STU:6JU0 17 E10 is €-6.18 as of Mar. 2026. GuruFocus rates STU:6JU0 with a GF Score™ of 17/100 and a GF Value™ of €0.01. The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioCardia's adjusted earnings per share data for the three months ended in Mar. 2026 was €-0.182. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-6.18 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was -5.50% per year. During the past 5 years, the average E10 Growth Rate was -17.50% per year. During the past 10 years, the average E10 Growth Rate was 2.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BioCardia was 54.90% per year. The lowest was -34.20% per year. And the median was 13.30% per year.

As of today (2026-07-14), BioCardia's current stock price is €0.27. BioCardia's E10 for the quarter that ended in Mar. 2026 was €-6.18. BioCardia's Shiller PE Ratio of today is .


BioCardia  (STU:6JU0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioCardia E10 Related Terms


BioCardia E10 Historical Data

* Premium members only.

The historical data trend for BioCardia's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioCardia E10 Chart

BioCardia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.21 -5.85

BioCardia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.81 -3.70 -5.66 -5.85 -6.18

STU:6JU0 vs GRTX, CELU, KTTA: E10 Comparison

For the Biotechnology subindustry, BioCardia's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioCardia Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioCardia's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioCardia's Shiller PE Ratio falls into.


STU:6JU0
17GF Score
BioCardia Inc STU:6JU0
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioCardia E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioCardia's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.182/330.2130*330.2130
=-0.182

Current CPI (Mar. 2026) = 330.2130.

BioCardia Quarterly Data

per share eps CPI Adj_EPS
201606 0.470 241.018 0.644
201609 28.869 241.428 39.486
201612 -52.318 241.432 -71.557
201703 -10.098 243.801 -13.677
201706 -9.612 244.955 -12.958
201709 -9.061 246.819 -12.122
201712 -10.520 246.524 -14.091
201803 -9.854 249.554 -13.039
201806 -9.758 251.989 -12.787
201809 -10.670 252.439 -13.957
201812 -11.207 251.233 -14.730
201903 -11.417 254.202 -14.831
201906 -10.222 256.143 -13.178
201909 -8.581 256.759 -11.036
201912 -6.480 256.974 -8.327
202003 -9.095 258.115 -11.635
202006 -6.127 257.797 -7.848
202009 -3.821 260.280 -4.848
202012 -1.849 260.474 -2.344
202103 -2.268 264.877 -2.827
202106 -2.490 271.696 -3.026
202109 -2.040 274.310 -2.456
202112 -2.788 278.802 -3.302
202203 -2.588 287.504 -2.972
202206 -1.987 296.311 -2.214
202209 -2.576 296.808 -2.866
202212 -2.266 296.797 -2.521
202303 -2.382 301.836 -2.606
202306 -2.326 305.109 -2.517
202309 -1.677 307.789 -1.799
202312 -1.210 306.746 -1.303
202403 -1.242 312.332 -1.313
202406 -0.818 314.175 -0.860
202409 -0.550 315.301 -0.576
202412 -0.477 315.605 -0.499
202503 -0.546 319.799 -0.564
202506 -0.347 322.561 -0.355
202509 -0.204 324.800 -0.207
202512 -0.158 324.054 -0.161
202603 -0.182 330.213 -0.182

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-6.18 mean?
BioCardia (STU:6JU0) has a E10 of €-6.18 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioCardia and its competitors.
Is BioCardia's E10 too high?
BioCardia's current E10 is €-6.18. Overall, BioCardia has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does BioCardia's E10 compare to GRTX and CELU?
BioCardia's E10 of €-6.18 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioCardia and its competitors. BioCardia's current E10 is €-6.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioCardia stock overvalued right now?
BioCardia (STU:6JU0) has a current E10 of €-6.18. The stock's GF Value™ is €0.01, compared to a current price of €0.27 — trading 2600% above its estimated fair value. The current E10 is €-6.18. BioCardia's overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For BioCardia (STU:6JU0), the current E10 is €-6.18 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioCardia (STU:6JU0) Overvalued in 2026?

Based on GuruFocus' analysis, BioCardia stock appears to be overvalued. The current stock price of €0.27 is trading 2600% above its estimated GF Value™ of €0.01.

Key valuation signals for STU:6JU0:

  • E10: €-6.18
  • GF Value™: €0.01 vs. price of €0.27 (2600% above fair value)
  • GF Score™: 17/100 with 1 warning sign

No single metric tells the full story. See the STU:6JU0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioCardia Business Description

Other Exchanges BCDA:USA
Address 320 Soquel Way, Sunnyvale, CA, USA, 94085
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
17GF Score

Get the complete analysis for STU:6JU0

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.27
Price
€0.01
GF Value